Oct 23, 2024, 03:42
Shushan Hovsepyan: Ruzanna Papyan on the accessibility of Anti-GD2 antibody therapy at SIOP 2024
Shushan Hovsepyan, Editor in Chief of the OncoDaily Medical Journal, shared on Linkedin:
”It was a pleasure to attend the session where Ruzanna Papyan presented on the accessibility of Anti-GD2 antibody therapy at SIOP 2024 in Honolulu.
This is super important topic. We should understand how we can overcome barriers and expand access to this life-saving treatment for children globally.”
Anti-GD2 antibody therapy
AntiGD2
cancer
cancer care
global health
Honolulu
International Society of Paediatric Oncology (SIOP)
OncoDaily
Oncology
pediatric oncology
Ruzanna Papyan
Shushan Hovsepyan
SIOP 2024
SIOP Europe
the European Society for Paediatric Oncology (SIOPE)
World Health Organization
Young SIOP
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25